Notably, Å6 inhibited the migration of a subset of ovarian and breast cancer cell lines in vitro by inducing high adhesion of the CD44-expressing cells to an HA substrate and altering CD44 conformation (79), obviously locking the cells to substrates of HA, abundantly found, e.g., in LNs. This evidence concerns the gene CD44 and breast carcinoma.